Ingredient news
Infant Formula Trial Finds No Body-Composition Shift From Milk Phospholipid Droplets
By Nutranexa News |
A controlled infant-formula trial found no measurable body-composition advantage from large milk phospholipid-coated lipid droplets enriched in dairy lipids during the first two years of life.
Trial Design
Healthy term infants were randomized to a concept formula with large, milk phospholipid-coated lipid droplets enriched in dairy lipids or to a conventional control formula, with an exclusively breastfed group used as a reference.
Body composition was followed through infancy and into toddlerhood with air-displacement plethysmography, DXA, and abdominal ultrasonography.
Main Result
The abstract reports no significant differences between the two formula groups for fat mass index standard deviation score or other body-composition trajectories through age two.
The concept formula was described as well tolerated and showed similar safety to the control formula.
Buyer Takeaway
For phospholipid and infant-nutrition suppliers, the study is useful because it tests a structural lipid design directly instead of treating all formula fat systems as interchangeable.
The result is also a reminder that premium lipid architecture does not automatically translate into a simple anthropometric win, so application teams still need endpoint-specific evidence.